Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-24-007138

EVP R&D, Chief Medical Officer gave up 3,414 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 7,689 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-23 Exercise or conversion : show line 1 in the form +7,689 113,123 D
2024-02-23 Shares withheld for taxes : show line 2 in the form −3,414 $29.57 $100,952 109,709 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-02-23 Exercise or conversion : show line 3 in the form Restricted Stock Unit Award −7,689 23,068 D
2024-02-26 Grant or award : show line 4 in the form Employee Stock Option (Right to Buy) +111,186 111,186 D
2024-02-26 Grant or award : show line 5 in the form Restricted Stock Unit Award +27,464 27,464 D
Loading xslF345X05/form4.xml…